All lobbying filings
MODERNA, INC.
MODERNA, INC. filed a Q3 report for MODERNA, INC. on October 16, 2026.
Lobbying for MODERNA, INC. · Pharmaceuticals
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 16, 2026
Expenses
$70,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
2
Lobbying activity
1
Vaccine Policy, FDA Vaccine Approval, mRNA Federal Policy, Oncology Innovation, Vaccines for Children Program, Patent Litigation